Loading provider…
Loading provider…
Nephrology Physician in Rochester, MN
NPI: 1174789796Primary Practice Location
MAYO CLINIC HOSPITAL ROCHESTER
201 W Center St, Rochester, MN
Primary Employer
Mayo Clinic - Mayo Building and Gonda Building
mayoclinic.org
HQ Phone
Get MD Ladan's Phone Numberphone_androidMobile
Get MD Ladan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMN State Medical License
IA State Medical License
2022 - 2026
IL State Medical License
2023 - 2026
MN State Medical License
2009 - 2026
ND State Medical License
2022 - 2026
MI State Medical License
2022 - 2025
WI State Medical License
2021 - 2025

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Nephrology
Mayo Clinic Alix School of Medicine - Rochester
college.mayo.edu
Fellowship • Nephrology
2011 - 2014
Residency • Internal Medicine
2008 - 2011
University of Toronto Faculty of Medicine
Medical School
Until 2008
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 60 | 131 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 39 | 56 |
| 3 | 99231Subsequent hospital inpatient care, typically 15 minutes per day | 24 | 34 |
| 4 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 22 | 22 |
| 5 | 90935Hemodialysis procedure with one physician evaluation | 19 | 30 |
Noninvasive Diagnosis of PLA2R-Associated Membranous Nephropathy: A Validation Study.
Authors: Andrew Bomback, Heedeok Han, Shahrzad Tehranian, Fernando Fervenza, Shane Bobart
Journal: Clin J Am Soc Nephrol
Publication Date: 2021-11-15
Clinical Findings, Pathology, and Outcomes of C3GN after Kidney Transplantation
Authors: Fernando Fervenza, Elizabeth Lorenz, Richard Smith
Journal: J Am Soc Nephrol
Publication Date: 2013-12-19
Lead Sponsor: Mayo Clinic
Collaborators: Genentech, Inc.
Intervention / Treatment: DRUG: Prednisone, DRUG: Omalizumab